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A B S T R A C T
Mesenchymal stem cells (MSCs) have been used in equines as an alternative therapy. A comparative study about
the phenotype and in vitro performance of different MSCs tissue sources in adult equines was needed. This study
might serve to provide the knowledge to select a valuable harvesting source of MSCs. Bone marrow, synovial and
adipose (mesenteric, neck and tail fat) tissues were collected from adult equines.
Cell surface markers expression (CD11α/CD18, CD45, CD79α, CD90, CD105 and MHC II) and in vitro dif-
ferentiation assays were made. In vitro cell migration, cell growth and wound healing capacity tests helped to
study their behavior and properties. MSCs phenotype was positively confirmed by the cell surfaces markers and a
tri-lineage differentiation profile. Bone marrow cells showed the highest migration capacity, while synovial fluid
cells displayed the highest cell growth. Bone marrow cells showed a better wound healing when compared with
all the different MSCs. We conclude that bone marrow, synovial and adipose tissue derived from adult equines
are a good source for cell therapy but they conserve different functional properties: bone marrow showed an
interesting migration and wound healing capacity while synovial fluid cells and their highest cell growth suggest
that these MSCs would yield higher cell numbers in a shorter time.
1. Introduction
Depending on their physical activity, equines' joints are exposed to
injuries having a negative impact on articulation tissue integrity and
homeostasis (Schlueter and Orth, 2004). During high locomotion ac-
tivities, i.e. horse racing, there is a constant stress on leg joint structure
to bear weight (Schlueter and Orth, 2004). This might cause trauma
that later would develop in diseases like osteoarthritis. Other factors
that predispose to osteoarthritis are the incorrect leg conformation and
progressive damage degeneration in the joint of elderly equines
(Schlueter and Orth, 2004). In equine medicine, different therapies like
the debridement of tissue, osteochondral implantation and grafting
techniques aim to improve joint problems (Ortved and Nixon, 2016).
Cell implantation of autologous or allogeneic cells in the injured tissue
seems to be a useful therapy showing tissue healing and a reduction in
size of the injured sites, thus appearing as a less invasive therapy (Hipp
and Atala, 2008). After cell implantation, an improvement of the his-
tological organization of damaged tissue and a decrease of the levels of
pathological pathways have been observed (Ortved and Nixon, 2016).
Mesenchymal stem cells (MSCs) have been used as a source for cell
implantation to repair joint damage (Hipp and Atala, 2008; Ortved and
Nixon, 2016). Among MSCs sources, bone marrow (BM) cells have been
largely used for implantation (Friedenstein et al., 1966). BM cells
usually are harvested from sternum or the ilium aspirates (Lombana
et al., 2015). The BM source is composed by a heterogeneous cell po-
pulation: mesenchymal fibroblast-like cells, hematopoietic cells and
diverse cell population that contribute to their differentiation capacity
in vitro (Elsafadi et al., 2016; Friedenstein et al., 1966). BM cells can be
obtained from different anatomical regions in the equines. Differences
between cell sources i.e. from ilium and sternum regions seem to be
minimal in respect to their multi-lineage differentiation (adipogenic,
osteogenic and chondrogenic) capacity on cells obtained from young
equines (Lombana et al., 2015). Other MSCs sources than BM have been
evaluated to be used in regenerative medicine. In 2002, Zuk et al. (Zuk
et al., 2002) showed adipose cells differentiation into mesodermal cells
demonstrating their differentiation capacity into other cell types. Adi-
pose cells have also been used to be differentiated into other cell types
showing a higher proliferative ability and doubling time in comparison
with BM cells (Colleoni et al., 2009). One of the advantages of choosing
adipose tissue as a source when obtaining MSCs is the higher amount of
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cells obtained after tissue digestion (Metcalf et al., 2016). However, the
region of adipose sampling yields differences in the number of viable
cells. Cells obtained from mesenteric adipose tissue show a higher
viability and more nucleated cells than those from tail head adipose
tissue in equines (Metcalf et al., 2016). In respect with the frequency of
stem cell number it seems they are more abundant on the abdominal
adipose tissues than in other adipose regions (Jurgens et al., 2008). The
expression of cell surface markers has helped to study the phenotype of
these cells (De Schauwer et al., 2011). The expression of CD90 cell
surface marker related with stemness and adipogenesis (Woeller et al.,
2015) and the expression of CD105 have been reported to be higher in
the omental fat than in the subcutaneal adipose tissue in dogs
(Requicha et al., 2012). In addition to adipose cells, synovial fluid cells
have also been suggested as an important source of MSCs. Synovial fluid
cells have been suggested to play an important role on cartilage re-
generation in equines (Murata et al., 2014). Apparently, synovial fluid
cells possess a high chondrogenic potential when compared with adi-
pose and BM cells. Although synovial fluid cells isolated from healthy
equines do not seem to be more abundant when compared with dis-
eased joints, synovial fluid remains an important source to obtain MSCs
(Murata et al., 2014). As mentioned before, synovial fluid seems a good
alternative MSCs harvesting source also because joints are a more easily
accesible and less invasive site by arthrocentesis.
Previous studies have shown that the anatomical sampling site re-
mains decisive for MSCs yield and might influence cell inner char-
acteristics (Metcalf et al., 2016; Requicha et al., 2012). Moreover the
overall donor horse condition has a strong impact on isolated MSCs. For
instance, adipose tissue cells (subcutaneous tail fat) obtained from
horses presenting equine metabolic syndrome represent an inefficient
MSCs source due to a decrease in cell proliferation rate, a less effective
osteogenic and chondrogenic differentiation, mitochondrial alteration
and an increased autophagy in cells (Marycz et al., 2016a; Marycz et al.,
2016b). This metabolic disorder is predisposed in ponies, Andalusian
and other equine breeds, it's influenced by the type of diet and related
to laminitis, an inflammatory disease in the hoof which in turn is re-
lated with osteoarthritis (Bamford et al., 2014). In addition, stemness,
cell differentiation capacity and cell growth properties might be crucial
for cell performance (Marycz et al., 2016a; Marycz et al., 2016b) within
the implanted tissue and their subsequent clinical outcome. Further-
more, cell deterioration related to senescence decreases MCSs pro-
liferation, modifications of the deoxyribonucleic acid and there is pre-
sence of high levels of oxidative stress factors (Kornicka et al., 2017).
Middle-aged horses (aged 10–13 years) differ in MSCs yield and cell
differentiation (Carter-Arnold et al., 2014), therefore donor conditions
and MSCs differences due to horse breed, nutrition and activity should
be carefully considered for each clinical case. To our knowledge, dif-
ferent studies (Carter-Arnold et al., 2014; Colleoni et al., 2009;
Lombana et al., 2015; Metcalf et al., 2016; Murata et al., 2014; Paebst
et al., 2014; Prado et al., 2015; Radcliffe et al., 2010; Ranera et al.,
2011; Zayed et al., 2017) have evaluated cell sources from BM, adipose,
and synovial fluid tissues, but no direct comparison of all reported
sources has been carried out from the same horses to date. In most cases
different tissues were sampled from different animals. In addition, a
detailed evaluation about cell phenotype and cell in vitro performance
associated with their harvesting site in adult equines has not been
performed. That is, MSCs harvested from donor-matched different
tissue sources (bone marrow, three different adipose tissue sites and
synovial fluid) has not been reported yet, and more importantly in vitro
assays to evaluate properties and compare behavior among donor-
matched sources that are related to their potential therapeutic appli-
cation were not performed on isolated cells. Thus, particular interest on
different tissue MSCs sources might help clinicians about the available
MSCs harvesting areas in cases where one tissue source would not be
suitable due to equine's condition (Bamford et al., 2014; Carter-Arnold
et al., 2014; Marycz et al., 2016b). In addition, the use of allogeneic
MSCs has been proposed as an alternative therapeutic source in equines
(Ardanaz et al., 2016). Therefore, the aim of this study was to evaluate
cell phenotype by analyzing the expression of cell surface markers that
were described for human MSCs and those reported in equines
(Dominici et al., 2006; Paebst et al., 2014) and then to test functional
properties of equine MSCs to evaluate cell migration, growth and
wound healing capacities. This study might help in the selection of an
appropriate tissue source to obtain MSCs for clinical applications in
equines.
2. Materials and methods
2.1. Tissue dissociation and equine mesenchymal cells culture
Samples from three mixed breed horses (10–16months old) were
collected at the slaughter house according to the Italian regulations
under the supervision of the Veterinary Services of the Italian National
Health Service, branch of the Ministry of Health. Tissue samples were
obtained as follows: BM (through scraping of the BM area of the
sternum), synovial fluid (radio carpal knee joint) and adipose tissue
from mesenteric, neck and tail base fat regions. Tissue samples were
collected within one hour from the slaughtering and cell isolation began
approximately one hour after collection. All sample tissues except from
synovial fluid were rinsed twice with PBS before the subsequent di-
gestion step. BM tissue (200mg) was washed with PBS and centrifuged
at 1200g then filtered through a 40-μm strainer. Later, BM cells were
cultured in proliferation medium (high glucose Dulbecco's Modified
Eagle's Medium (DMEM) 1X (Sigma-Aldrich), 10% fetal bovine serum
(FBS) (Gibco), 4.5 g/l D-Glucose, 2 mM L-Glutamine, 2.5 μg/ml ampho-
tericin B and 1% penicillin-streptomycin (all from Sigma-Aldrich).
Tissue from different adipose areas (neck fat 2 g, tail fat 1 g, mesenteric
fat 500mg - approximately) were washed with PBS and cut in small
pieces and digested with 250 U/ml collagenase type I (BD Bioscience) at
37 °C for 3–4 h. Then, adipose tissue was centrifuged at 1200g, filtered
with a 40-μm strainer and cells were cultured in proliferation medium.
2ml out of the recovered 5–7ml of synovial fluid were gently mixed
with 3ml proliferation medium and directly seeded on culture dishes.
The cells obtained from BM, synovial fluid and adipose tissue were
cultured respectively in a 100mm diameter tissue culture dish
(Sarstedt). After 24 h in culture, medium was replaced with fresh one to
eliminate non-adherent cells. Cells were cultured at 37 °C with 5% CO2
in proliferation medium until confluence then split in new cell culture
dishes.
2.2. Flow cytometry of equine mesenchymal cells
Cells were detached with 0.25% trypsin–EDTA (Sigma-Aldrich) then
counted, washed with PBS and centrifuged at 500g for 5min. Aliquots
of 250,000 cells per tube were prepared and washed with PBS. Cells
were then incubated at 4 °C in the dark with CD11α/18-FITC (clone
CVS9 horse, 1:160) (BioRad), CD45-Alexa Fluor 488 (clone F10-89-4
human, 1:160) (BioRad), CD79α-Alexa Fluor 488 (clone HM57 human,
1:80) (BioRad), CD90-PE (clone Thy1-A1human, 1:400) (R&D
Systems), CD105 (clone SN6 human 1:80) (BioRad) and MHC-II-FITC
(clone CVS20 horse, 1:80) (BioRad) antibodies for 15min. The cells
labelled with the CD105 antibody were then washed and incubated
with an anti-mouse IgG Pacific blue-conjugated secondary antibody
(1500) (Invitrogen). Cells were washed with PBS and tubes were cen-
trifuged at 500g for 5min at 4 °C. Cells were re-suspended with PBS for
further flow cytometry analysis. Control samples served to establish
acquisition parameters on each cell type to select the population of
interest. For data analysis 20,000 events were collected using an
Attune® Cytometer (Life Technologies) equipped with a 405 nm and a
488 nm laser. The data obtained was analyzed with the Attune®
Cytometric Software.
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2.3. Cell tri-lineage differentiation
To evaluate equine mesenchymal cell adipogenic differentiation
capacity, 5000 cells/well were plated in a 6-well dish (CytoOne,
Starlab). The osteogenic differentiation capacity of cells was evaluated
by seeding 15,000 cells/well in a 6-well dish (CytoOne, Starlab). For the
chondrogenic differentiation, 5×105 cells were seeded in a 2ml tube
with round bottom to allow a three-dimensional spontaneous cell ag-
gregation. Differentiation StemPro® (Gibco) medium was used for adi-
pogenic, osteogenic and chondrogenic differentiation respectively ac-
cording to manufacturer instructions. For all cell differentiation
cultures, medium was replaced every two days and cells remained in
culture for around 14-days in the case of adipogenesis and chon-
drogenesis, while for osteogenic differentiation, two stages were tested:
positivity to alkaline phosphatase activity (~7 days of culture) and up
to 21 days for final osteogenic differentiation.
2.4. Histological evaluation of cell tri-lineage differentiation
After culturing the cells in the appropriate differentiation medium,
the medium was removed and cells were washed with PBS carefully.
Cells cultured in adipogenic medium were fixed with 4% formalin and
subsequently stained with Oil Red O. Pre-osteogenic differentiation was
analyzed with the alkaline phosphatase staining kit (Sigma-Aldrich)
following manufacturer's instructions. For osteogenic differentiation
cells were fixed with 4% of formalin and stained in the dark with
Alizarin red. Chondrogenic cells formed a micromass structure which
was carefully washed with PBS and fixed overnight with 4% formalin.
The micromass structures were incubated in 80% ethanol and then
embedded in paraffin. Sections were cut at a 5 μm thickness. The slides
were deparaffinized and incubated in Safranin O. Slides were mounted
with EUKITT® mounting medium and images were taken after 24 h.
2.5. Cell migration
Three replicate wells were set up for each different cell type (BM,
synovial fluid and adipose tissues) from each of the three horses. A total
of 50,000 cells/well were plated on 8 μm TC-inserts (Sarstedt) in 24-
dish (CytoOne, Starlab) with proliferation medium. After 24 h of in-
cubation, medium was removed, then inserts were washed with PBS
and the upper side of the membrane was cleaned carefully with a cotton
swab. Inserts were fixed with 4% formalin for 20min, after fixation
they were washed with deionized water and the upper side of the
membrane cleaned again with a cotton swab. Finally, inserts were in-
cubated with DAPI and analyzed with an inverted fluorescent micro-
scope (Leica as previously described). An image of the entire lower side
of the TC-insert membrane was captured with a 10x objective using the
LAS AF software and nuclei were counted with ImageJ software.
2.6. Mesenchymal equine cells growth assessment
To estimate cell growth, each cell type was seeded in a 6-well plate
(CytoOne, Starlab) with proliferation medium at a density of 20,000
cells/well. The experiment was performed from each of the three
horse's harvested tissue, and duplicates were made on each different
type of tissue. Cells were incubated and cell numbers were assessed at 0,
24 and 48 h. The medium was discarded and cells were fixed with
methanol-acetone (1:1 vol/vol) which was subsequently replaced with
Tris-HCl buffered saline (0.1 M Tris-HCL, 8 g/l NaCl, pH 7.6). Cells were
incubated with 4′6-diaminide-2′-phenylindole dihydrochloride (DAPI)
(Sigma-Aldrich) to stain nuclei and images were acquired at 10x mag-
nification in five different random areas per well with an inverted
fluorescent microscope Leica AF6000 LX equipped with a Leica
DFC350FX digital camera (Leica Microsystem, Wetlar, Germany).
Images were analyzed with ImageJ software (1.48version) to auto-
matically count the stained nuclei in each image. Cell growth was
expressed as ratio of nuclei counted at 24 h or 48 h and the nuclei count
from the same well at time 0.
2.7. Wound healing assay
The wound healing assay (or scratch assay) consisted on creating a
gap in a confluent cell monolayer, capturing the images to quantify the
gap filling rate. Endothelial cells harvested from equine carotid artery
were kindly provided by Dr. Walid Azab from the Free University of
Berlin (Freie Universität Berlin, Institut für Virologie Robert von
Ostertag-Haus-Zentrum für Infektionsmedizin, Germany). Endothelial
cells were seeded at a density of 150,000 per well in collagen coated 24
well plates (CytoOne, Starlab) and cultured with DMEM supplemented
with 20% FBS and 1% non-essential amino acids (aa) until confluence
(usually 24 h). When cells reached confluence, a scratch was made with
a 1000 μl tip. Cell monolayers were washed with PBS and the medium
was replaced with one suitable for the appropriate experimental con-
dition. Briefly, two conditions were set up and for each one 3 replicate
wells were prepared: co-culture with MSCs or MSCs conditioned
medium. In the co-culture condition 24,000 MSCs at passage 1 from
each tissue source were seeded in individual transwells (Sarstedt TC-
inserts with a 1 μm porous membrane). Culture medium was switched
to DMEM 2% FBS with 1% non-essential aa. As control, transwells
prepared with 24,000 endothelial cells were used and processed in the
same way. To test the effect of conditioned medium, MSCs were seeded
at passage 0 until confluence. Culture medium was then changed to
fresh DMEM 10% FBS. After 48 h conditioned medium was collected
and immediately added to the appropriate wells were the scratches on
endothelial cells were already performed. For this condition control was
set up using 48 h conditioned medium from endothelial cells (DMEM
10% FBS). Images were acquired with a 10x objective at the time the
scratches were performed (time 0) and after 16 h in culture. Three
adjacent areas were photographed per each well. The images were then
analyzed by Image J software with the MRI Wound Healing Tool to
calculate gap areas. Gap areas at 16 h were normalized to their re-
spective time 0 measurement and therefore data are presented as a
ratio.
2.8. Statistical analysis
Flow cytometry data are expressed in percentages as mean ±
standard deviation. For cell growth and cell migration results nor-
malization was made and differences among the different tissue sources
were estimated by a non-parametric test Kruskal-Wallis followed by a
post-hoc pairwise comparison Wilcoxon-Mann-Whitney test. Wound
healing statistical analysis was performed by a Kruskal-Wallis in-
dependent sample test followed by a post-hoc pairwise comparison
Wilcoxon-Mann-Whitney test. A p-value of< .05 was considered sta-
tistically significant. The statistical analysis was performed with SPSS
Statistics version 24 (IBM SPSS Statistics®, USA).
3. Results
After tissue dissociation, cells were cultured in vitro with prolifera-
tion medium (Supplementary Fig. 1) until confluence. An important
characteristic of MSCs is to adhere to plastic after culture.
Subsequently, cells were analyzed by flow cytometry with cell surfaces
markers that have been described in mesenchymal cells of several
species, including the equine one (De Schauwer et al., 2011; Dominici
et al., 2006).
3.1. Flow cytometry
BM, synovial fluid and adipose tissues are constituted by different
type of cells. To identify mesenchymal cells, cultured cells were ana-
lyzed by flow cytometry using cell surface markers CD11α/CD18,
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CD45, CD79α, CD90, CD105 and MHC Class II. We show representative
plots of all markers tested for cells isolated from all sites in Fig. 1, with
2 peaks, one being the negative control (FMO) and the other one the
cells incubated with the appropriate antibody. In Supplementary
Table 1, data results show the percentages of positive cells with their
respective standard deviation. After the flow cytometry analysis, we
could observe that the cells obtained from BM expressed the least CD90
when compared with synovial and adipose tissue cells (Supplementary
Fig. 3). Among all the tissues, synovial fluid cells had a slightly higher
expression of CD11α/CD18, CD45, CD79α and MHC II, but the overall
positivity was low to negative nonetheless. Most of the adipose tissue
cells showed the highest expression of CD105 when compared with BM
and synovial fluid cells (Supplementary Fig. 3). Moreover, CD90 was
also highly expressed in all three adipose tissue cells (Supplementary
Fig. 3). In contrast, CD45 and CD11α/CD18 had a lower expression in
all of the adipose tissue cells when compared with BM and synovial
fluid cells. Neck fat and tail fat cells had a higher CD79α, CD90, CD105
and MHC II expression compared with mesenteric fat. In the case of tail
fat cells, they showed the highest CD90 expression, while neck fat
presented the highest expression of CD105 of all the three adipose
tissue cells (Supplementary Fig. 3). Mesenteric fat tissue cells expressed
the least CD11α/CD18, CD45, CD79α and MHC II compared with BM,
synovial fluid, neck fat and tail fat cells. Generally, synovial fluid cells
showed expression of all cell surface markers tested and was the po-
pulation with the highest frequency of CD11α/CD18+, CD45+,
CD79α+ and MHCII+ cells. Only in synovial fluid cells CD45 and
MHCII positive cells had a frequency above 2% (2.033 and 3.164 re-
spectively). CD90 and CD105 expression showed higher variability as
detailed in Supplementary Table 1, ranging from 9.132% to 97.043%
and from 13.22% to 84.285% respectively.
3.2. Cell differentiation
Cells were cultured with differentiation media with the objective to
evaluate their capacity to go through tri-lineage (adipogenic, chon-
drogenic and osteogenic) differentiation. This is a characteristic
Fig. 1. Flow cytometry analysis of the different types of cells obtained from BM, synovial and adipose tissues. Each histogram displays a blue curve that corresponds
to the FMO control and a red curve that shows the cells stained with the indicated antibody. Gates were drawn according to the FMO controls. (For interpretation of
the references to colour in this figure legend, the reader is referred to the web version of this article.)
M. Arévalo-Turrubiarte, et al. Stem Cell Research 37 (2019) 101442
4
expected when obtaining MSCs. Adipogenic differentiation was vali-
dated by Oil Red O staining after 14 days in culture. Fig. 2A shows on
the upper side the controls (with proliferation medium), whereas on the
bottom a representative image of the cells in differentiation conditions
has been reported. All the cells treated with differentiation medium
were positively stained with Oil Red O. Control cells shape was large
whereas in treated cells it was round and flattened. The Oil Red O
staining allowed to observe the presence of lipid droplets within the
cells that underwent adipogenic differentiation in treated cells. Overall,
adipose cells showed a more intense staining when compared to BM or
synovial fluid cells. Mesenteric cells (Fig. 2A6) differentiation is more
evident and showed the presence of typical lipid droplets within adi-
pose cells. For the chondrogenic differentiation, the micromass or pellet
was formed. The pellet size of the chondrogenic treated cells was larger
(images not show) in comparison with the controls. The control pellet
aggregates did not show a defined structure and a basal Safranin O
staining (Fig. 2B) was observed in the synovial and mesenteric controls
(Fig. 2B3 and B5). Pellets formed by cells undergoing chondrogenesis
that were stained with Safranin O (bottom images on Fig. 2B) showed a
red and more defined nuclei structures when compared to controls.
Osteogenic pre-differentiation was evaluated by alkaline phosphatase
staining. All the controls in proliferation medium were not stained
whereas on the bottom side, all the treated cells showed the positive
staining for alkaline phosphatase pre-osteogenic differentiation in all
the different cell types (Fig. 3A). Final osteogenic differentiation was
detected by Alizarin red staining and treated cells showed irregular
shape. As shown in Fig. 3B, in all the osteogenesis induced cell types
positive red stained areas were detected, confirming final osteogenic
differentiation by the presence of calcium deposits.
3.3. Cell migration
Migration cell capacity and motility was performed on all cells by
the use of porous membrane inserts (transwells). This migration assay
might give us information on the ability of cells to move through a
porous membrane which could be related to their capacity to migrate in
vivo. At 24 h, we could observe that there were significant (p < .05)
differences in the migration capacity of BM against mesenteric and neck
fat cells (Fig. 4). Within the adipose tissue cells, tail fat showed a higher
tendency to migrate when compared with mesenteric and neck fat;
however migration was not statistically different (p > .05) among cells
recovered from the different adipose tissues (Fig. 4). Tail fat, BM and
Fig. 2. Adipogenic and Chondrogenic differentiation on MSCs. A: Adipogenic differentiation after 14 days on monolayer culture with proliferation medium (Control)
and differentiation medium (DM). A: Adipogenic cells were stained with Oil Red O. Panels 1-3-5-7-9 are representative pictures of cells cultured in growth medium
and stained with Oil Red O. Panels 2-4-6-8-10 are the corresponding cells grown in differentiation medium and stained Oil Red O. Shape morphology differs in DM
treated cells (flattened and round) vs controls (large cells). B: Chondrogenic differentiation was evaluated after 14 days on round bottom tubes. The cell aggregation
formed a pellet that was stained with Safranin O after inclusion in paraffin and sectioning. Panels 1-3-5-7-9 are representative pictures of cells cultured in growth
medium, while panels 2-4-6-8-10 are grown in differentiation medium. Treated cells with chondrogenic media show a more defined cell nuclei than control cells.
Images were obtained with a 40x objective (scale bar is 50 μm). (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
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Fig. 3. Osteogenic differentiation on MSCs. A: Osteogenic differentiation was evaluated after 7 days in differentiation medium and growth medium on monolayer
cultures. Alkaline phosphatase analysis was performed. Panels 1-3-5-7-9 show control cells, while panels 2-46-8-10 show cells grown in differentiation medium.
Control cells looks large without specific staining whereas treated cells showed a different morphology (bigger and irregular shape) and intense red/purple staining.
B: Final osteogenic differentiation was performed after around 21 days on monolayer culture. Cells were stained with alizarin red, panels 1-3-5-7-9 are representative
images of controls in growth medium, while panels 2-46-8-10 are images of cells grown in differentiation medium. Osteogenic positive cells showed a red staining
and a different morphological shape. Images were obtained with a 10x objective (scale bar is 250 μm). (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
Fig. 4. Cell migration capacity of BM, synovial and
adipose cells. Columns represent quantification of
cell migration capacity as nuclei counts of the cells
that were attached on the lower side of the porous
membrane. Results are representative of three an-
imal replicates, each one done in triplicate.
Differences on letters above the columns indicate
statistically significant differences (p < .05).
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synovial fluid were not significantly different and mesenteric and neck
fat cells seem to be likely similar on their migration capacity. Synovial
fluid cells showed a statistically significant higher migration capacity
(p < .05) than mesenteric and neck fat cells.
3.4. Cell growth
To study an additional characteristic of these cells, we decided to
analyze in vitro cell growth. Cells were plated in 6-well dishes and were
evaluated at two different times (24 and 48 h). Within the 24 h in
culture, BM, mesenteric and neck fat did not show significant differ-
ences (p > .05) (Fig. 5) in cell growth. For the cells from mesenteric
and tail fat, cell growth was not significantly different (p > .05), this
was also the case between mesenteric and neck fat (p > .05) (Fig. 5).
Synovial fluid cells were significantly different (p < .05) when com-
pared with BM and all the adipose cells, showing a higher amount of
cells after 24 h in culture (Fig. 5).
When the analysis was repeated at 48 h, we could observe that BM
and neck fat cells were significantly different (p < .05) from mesen-
teric, tail fat and synovial fluid cells (Fig. 5). Adipose (mesenteric and
tail fat) cells were similar between them and significantly different
(p < .05) from neck fat cells (Fig. 5). Finally, synovial fluid cells seems
to grow significantly more (p < .05) (Fig. 5). Cell culture length seems
to modify cell growth in all samples. Adipose cells growth patterns from
mesenteric cells become significantly different (p < .05) from BM cells
after 48 h in culture (Fig. 5). In both cases, synovial fluid cells remain
significantly different within both 48 and 24 h in culture, presenting the
highest cell growth capacity in in vitro cultures.
3.5. Wound healing assay
MSCs derived from BM, synovial fluid and adipose tissues were
seeded in a co-culture with endothelial cells to analyze their ability to
improve the wound healing capacity of a target cell population by re-
plenishing a scratch area. After 16 h of being in culture, differences on
the amount of cells that were able to migrate to the wound healing area
was analyzed. We could observe that among the different type of MSCs
there were not statistically significant differences (p < .05) with the
controls (endothelial cells) when they were seeded in a co-culture
system (Fig. 6). However, when conditioned medium from MSCs was
used a statistically significant difference (p < .05) was observed as the
BM cells were the only ones to improve scratch filling (Fig. 7). BM cells
were the cells that were able to largely recover wound healing areas
when compared with other type of MSCs. Representative images at time
0 and 16 h are shown (Supplementary Fig. 2).
4. Discussion
We described here different MSCs obtained from BM, synovial and
adipose tissues from adult equines. We were able to confirm their MSCs
identity and to evaluate in vitro performances and capabilities of MSCs
isolated from different sources. We propose here that different sources
might impact MSCs properties from adult equines for putative use in
cell therapy. Comparison of different MSCs sources could also prove
valuable for veterinarian clinicians in case the equine's capacity as a
donor might not be adequate due to age, or inadequate health condition
(Bamford et al., 2014; Carter-Arnold et al., 2014; Schlueter and Orth,
2004). Such information would allow clinicians to select for an alter-
native source. When we obtained these cells after several days of in vitro
culture, we were able to observe the typical MSCs fibroblast-like spindle
morphology in our cells (De Schauwer et al., 2011). However, in BM
cells we observed different cellular morphology which reflect their
Fig. 5. Cell growth of BM, synovial and adipose cells. Columns represent quantification of cell growth as ratio of nuclei counted at a specified time point (24 h or
48 h) and nuclei counted at time 0. A: Cell growth at 24 h B: Cell growth at 48 h. Results are representative of three animal replicates. Differences on letters above the
columns indicate statistically significant differences (p < .05).
Fig. 6. Wound healing in vitro assay of endothelial cells in a co-culture with
MSCs. Columns show the ratio between the wound area measured at 16 h and at
time 0 when co-culture was performed. Each different type of mesenchymal
cells was performed in replicates from each animal (n=3). Asterisk (*) in-
dicates statistically different (p < .05). Scale bars represent S.E.M.
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heterogeneous population (Elsafadi et al., 2016). Other studies have
evaluated cells obtained from different sources i.e. BM and adipose
tissue (Ranera et al., 2011) however, tissue collection areas were dif-
ferent in our study. For instance, adipose tissue is mostly obtained from
the tail base region (Ranera et al., 2011) but adipose cells (from the tail
base) obtained from equines with metabolic syndrome decrease in their
potency, proliferation and differentiation capacity when compared with
healthy adipose cells (Marycz et al., 2016b). We therefore further
compared cells derived from other adipose tissues. We selected me-
senteric fat because of its ease of processing and its reported high cell
viability (Metcalf et al., 2016). We also decided to obtain synovial fluid
cells from slaughtered animals to evaluate their mesenchymal nature
and culture properties since there are reports of such cells isolated from
synovial fluid of live equines (Murata et al., 2014). Since MSCs have
been studied for transplantation purposes (Ortved and Nixon, 2016;
Schlueter and Orth, 2004), our results show that BM followed by sy-
novial fluid cells possess a higher migration capacity than other
sources. Moreover, cells obtained from synovial fluid have a higher cell
growth in vitro.
When performing the phenotype analysis on equine MSCs, we
decided to be consistent with the minimal criteria that have been de-
fined by Dominici et al. (Dominici et al., 2006), so we analyzed the
expression of specific markers associated both with an MSCs phenotype
and a non-MSCs phenotype. Such criteria would demand a frequency
lower than 2% for CD45+, CD11α/18+, CD79α+, MHCII+ cells and
higher than 95% for CD90+ and CD105+ cells. However, such fre-
quencies are defined for human MSCs and in other species variations
can be expected as different frequencies have been reported for the
equine species (Paebst et al., 2014). We could find a low percentage of
CD45+ cells in synovial fluid, just above the threshold. We hypothesize
that this expression could possibly relate to the sampling site and
procedure. A low percentage of synovial fluid cells expressed MHC-II.
The low frequency of MHC-II+ cells in our study is in concordance with
other studies (Murata et al., 2014), and MHC-II expression might be
limited to early passages and decreasing in later passages (Radcliffe
et al., 2010). However, MSCs heterogeneity and MHC-II expression
differ in the equine species according to age as reported (Schnabel
et al., 2014). Moreover, a very low frequency of MHC-II+ cells is im-
portant for the MSCs value in cell therapy (Schnabel et al., 2014) since
MHC-II+ cells could trigger an immune response.
Thus, the low, albeit above threshold, frequency of MHC-II+ cells
present in synovial fluid in our study suggest that MSCs obtained from
this tissue should be carefully considered for allogeneic transplantation.
According to defined criteria, MSCs should express CD90 and
CD105 (De Schauwer et al., 2011; Dominici et al., 2006). The CD90+
cells in mesenteric, neck and tail fat cells are well documented in equine
MSCs and serve as “identifiers” of these type of cells (Ranera et al.,
2011). Consistent with other studies (Metcalf et al., 2016), our data
show that in tail and neck fat, CD90+ cells were detected. However, our
data show a lower CD90 expression in mesenteric cells, compared to
that of tail and neck fat cells. This could be explained by our metho-
dological analysis, since we analyzed CD90 by flow cytometry while
Metcalf et al. (Metcalf et al., 2016) measured gene expression. Another
possible explanation of this is that the sampling collection site might
influence mesenteric cell type CD90 expression, since mesentery is a
large tissue. CD90+ cell frequency in synovial fluid and BM cells in our
study were consistent with other experiments (Paebst et al., 2014;
Prado et al., 2015). In our study, CD105 expression was found in all
types of MSCs including adipose-derived cells even though at frequency
lower than 95%. Even though a high frequency of expression is re-
quired, our data are consistent with similar CD105 expression in equine
adipose (Paebst et al., 2014) and synovial fluid cells (Prado et al.,
2015). CD105 has been used to characterize MSCs with a possible
chondrogenic potential due to its relationship with the transforming
growth factor beta (TGF-β) complex which stimulates chondrogenic
differentiation (Cleary et al., 2016). However, CD105 expression by
itself should not be directly associated with chondrogenic potential in
cells (Cleary et al., 2016). We not only found the surface marker ex-
pression to be consistent with previous reports, but we also confirmed
the MSCs identity through tri-lineage differentiation. Mesenteric fat
cells showed a more evident lipid droplet content with Oil Red O
staining, which might be related to visceral tissues having a more li-
political activity when compared to other adipose tissues, like sub-
cutaneous fat (Bjorndal et al., 2011). Among all of the tissues, synovial
fluid cells showed the highest Safranin O staining and a more defined
cell morphology. This might depend on their origin being closer to a
chondrogenic differentiation fate, as it has been prevously described by
Zayed et al. (Zayed et al., 2017). It has been observed that synovial fluid
cells improve regeneration by hyaline cartilage production and re-
construct the defected area when implanted in vivo in murine articu-
lations (Zayed et al., 2018b). BM, synovial and adipose cells were able
to differentiate into osteocytes. The higher or lower differentiation
potential in cells might vary among donors (Zayed et al., 2017).
Moreover, in the case of equine synovial fluid cells, even if they might
represent a less invasive MSCs harvesting site in equines, there is still
the challenge of further evaluating their use in intra-articular injections
i.e. osteoarthritis to support their clinical application (Zayed et al.,
2018a).
The highest BM cell migration reported herein could relate to a
higher motility and infiltration capacity (Smith et al., 2012). In our
study, cell migration was evaluated at the first passage. BM cells results,
followed by synovial fluid cells, in the migration assay might depend on
their efficiency to move through sites of injury and thus influence their
progenitor/stemness and environment interaction (Augello et al.,
2010). Their migration ability might also depend to a varying extent to
the extracellular matrix they were isolated from. As for adipose-derived
cells, their cell migration capacity is not extensively developed
(Cabezas et al., 2018).
Cell growth is a meaningful characteristic to consider when using
MSCs for cell therapy, because cell expansion is needed in order to
obtain a significant amount of cells for transplantation. After evaluating
in vitro cell growth we might suggest that synovial fluid cells possess an
adequate cell expansion in culture. MSCs isolated from equines suf-
fering joint diseases have a higher proliferation rate when compared
with synovial fluid cells from healthy equines (Murata et al., 2014).
However, if the implantation of MSCs from healthy horses resulted in
an increased inflammatory response (Ardanaz et al., 2016), such an
effect might even be higher when using MSCs from diseased joints and
therefore more studies should focus on this issue. In our study, the
Fig. 7. Wound healing in vitro assay of endothelial cells with conditioned
medium from MSCs Columns show the ratio between the wound area measured
at 16 h and at time 0 when conditioned medium derived from MSCs was used.
Each conditioned medium was derived from each type of MSCs cell and re-
plicates were made from each animal (n=3). Asterisk (*) indicates a statisti-
cally significant difference (p < .05). Scale bars represent S.E.M.
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higher growth rate of synovial fluid cells might be related to the type of
stem/progenitor cells contained within the tissue niche (Prado et al.,
2015). When comparing BM against adipose-derived cells in our study,
we could observe that neck fat cells had an almost similar cell growth at
24 and 48 h.
In vitro wound healing assay in a co-culture with endothelial and
MSCs did not show significant differences. Neck fat MSCs efficiency to
refill scratch area has been reported on adipose equine cells (Cabezas
et al., 2018) obtained from the rump region (tail fat). However, in our
study we could observed that neck fat cells were more effective in
wound healing repair than tail fat cells. Only when adding conditioned
media from BM derived MSCs to the in vitro cultures, we detected a
statistically significant improvement in wound repair. Our results sug-
gest that BM cells might release some paracrine factors (i.e. chemo-
kines) that enhance scratch repair (Smith et al., 2012) and that this
secretion occurs at low rate, so that an extended time period is neces-
sary to have the necessary accumulation that results in a biological
effect, hence the enhancement of wound healing repair when condi-
tioned medium was used vs co-cultures.
The tissue cell sources in our study provide a more extended over-
view of MSCs compared characteristics different from the typically BM
and adipose tail fat cells largely described in equines literature.
5. Conclusion
We demonstrate that MSCs from BM, synovial fluid and adipose
(mesenteric, neck and tail fat) tissue from adult slaughtered equines
could be valuable candidates as an allogeneic source for cell therapy,
although they show different phenotypes and properties. All cell types
were able to grow on monolayer cultures, to differentiate into the tri-
lineage adipogenesis, chondrogenesis and osteogenesis, confirmed by
all their MSCs characteristics. In the case of BM cells, we could observe
that they possess an important migration capacity and might be useful
during implantation. Media obtained from BM cell cultures might
contain molecules that enhance wound healing repair more effectively
than the media from other MSCs. In contrast, synovial fluid cells are a
good source for obtaining MSCs in a shorter time due to their cell
growth and they might be suggested as a source of rapidly expanding
MSCs. Phenotype and performances of each different MSCs source
should then be considered when making a choice in selecting MSCs. In
some case, higher proliferation rates might be more desirable to reduce
the time between sampling and transplantation, while in others the
more important property might be a higher paracrine effect. Our data
might help veterinarian clinicians decide which source is more con-
venient and appropriate for the condition of each individual patient.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.scr.2019.101442.
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